Last reviewed · How we verify
Prothrombin time — Competitive Intelligence Brief
marketed
Hematology/Coagulation Monitoring
Biologic
Live · refreshed every 30 min
Target snapshot
Prothrombin time (Prothrombin time) — University Hospital, Strasbourg, France. Prothrombin time (PT) is a laboratory test that measures the time it takes for blood plasma to clot, reflecting the function of extrinsic and common coagulation pathway factors.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prothrombin time TARGET | Prothrombin time | University Hospital, Strasbourg, France | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prothrombin time CI watch — RSS
- Prothrombin time CI watch — Atom
- Prothrombin time CI watch — JSON
- Prothrombin time alone — RSS
Cite this brief
Drug Landscape (2026). Prothrombin time — Competitive Intelligence Brief. https://druglandscape.com/ci/prothrombin-time. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab